| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/20/2023 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 267k | $1.11 | $296.4k | | 01/20/2023 |
| 01/19/2023 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 103.3k | $1.22 | $126k | | 01/17/2023 |
| 01/18/2023 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 33.7k | $1.25 | $42.2k | | 01/17/2023 |
| 01/17/2023 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 27.2k | $1.31 | $35.6k | | 01/17/2023 |
| 03/31/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 100k | $1.44 | $144k | | 03/31/2022 |
| 12/21/2021 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 800k | $1.44 | $1.2M | | 12/21/2021 |
| 12/03/2021 | Outlook Therapeutics, Inc. | ONS | Purchase | Common Stock | 35.2k | $1.34 | $47.2k | | 12/03/2021 |
| 02/23/2021 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 8.6k | $2.09 | $17.9k | | 02/23/2021 |
| 02/12/2021 | Outlook Therapeutics, Inc. | ONS | Sale | Common Stock | 57k | $2.55 | $145.3k | | 02/12/2021 |
| 03/19/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 1.2M | $0.00 | $0 | | 03/19/2020 |